跳至主要内容
临床试验/RBR-6wg54rb
RBR-6wg54rb进行中(未招募)3 期

Sleep Duration Variability: a Therapeutic Target of Melatonin for Glycemic Control in patients with Type 2 Diabetes Mellitus

niversidade Federal de Minas Gerais0 个研究点开始时间: 2021年2月22日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
40Y 至 0(—)

入选标准

  • This project will include patients diagnosed with diabetes mellitus type 2 for more than one year; age greater than or equal to 40 years; family history of diabetes mellitus type 2; glycosylated haemoglobin between 7 and 10%

排除标准

  • Pregnancy; corticosteroids use within less than 3 months; or other medications that elevate glycemia; diseases that significantly alter glycemia stability (renal failure, acute coronary syndrome, cancer, liver failure, among others); uncontrolled diabetes, with polydipsia, polyuria, or weight loss requiring insulin or other drugs; high risk for severe sleep apnea; depression; shift work; epilepsy; refusal to participate in this research at any time

研究者

发起方
niversidade Federal de Minas Gerais

相似试验